Description
EO 14398
Base award description: RADIOPHARMACEUTICALS SUPPLIES
First action · last action
2023-03-30 · 2026-05-22
Transactions
5
First transaction's obligation
$0
Base + all options value (sum of deltas)
$2,674,780
Extent competed
—
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-03-30+$0= $0
- Mod P000012023-04-13+$0= $0
- Mod P000022023-09-29+$0= $0
- Mod P000032024-03-08+$0= $0
- Mod P001002026-05-22+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-03-30 | +$0 | $0 | RADIOPHARMACEUTICALS SUPPLIES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2023-04-13 | +$0 | $0 | STOP WORK ORDER RADIOPHARMACEUTICALS SUPPLIES |
| Mod P00002· UNIQUE ENTITY ID OR LEGAL BUSINESS NAME CHANGE - NON-NOVATION | 2023-09-29 | +$0 | $0 | NAME CHANGE AGREEMENT |
| Mod P00003· EXERCISE AN OPTION | 2024-03-08 | +$0 | $0 | NAME CHANGE AGREEMENT |
| Mod P00100· OTHER ADMINISTRATIVE ACTION | 2026-05-22 | +$0 | $0 | EO 14398 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NULVGFUNYLS9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0409 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $266,038 | FY2026 |
| 36C25625N0618 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $216,573 | FY2025 |
| 36C25624N0616 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $264,691 | FY2024 |
| 36C25623P0794 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $48,686 | FY2023 |
| 36C25623N0686 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $155,196 | FY2023 |
| 36C25623P0028 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $133,187 | FY2023 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626N0555 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $654,692 | FY2026 |
| 36C25626P0618 | HANGER PROSTHETICS & ORTHOTICS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $15,119 | FY2026 |
| 36C25626N0492 | BAYER HEALTHCARE PHARMACEUTICALS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $386,860 | FY2026 |
| 36C25626N0469 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $396,000 | FY2026 |
| 36C25626N0461 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $271,226 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C25623A0025_3600 · retrieved 2026-09-26.